Ian McCubbin CBE
Chair of Cell and Gene Therapy Catapult, Chair of RoslinCT
Ian has a passion for biological science, in particular Cell and Gene Therapy due to the transformational medical benefits and the potential economic benefit created for the UK by this innovative treatment platform.
Mark Cook
Chair, Life Sciences Scotland
Mark has spent 30 years in roles within the health sector including biologicals/pharmaceuticals, medical technology, consultancy and is experienced in raising funding plus has successfully led a pharma company startup to an exit.
Dr Glenn Corr
Chief Operating Officer and Chief Business Officer, TauRx
Dr Corr has over 30 years’ experience in technical, commercial and operational roles in high risk, capital intensive, industries. He has previously served as Operations Director of EnQuest, Asset and HSEQ Director, and Commercial Manager for Maersk, and a Principal Consultant at DNV. He holds a PhD in Systems Engineering, an MBA, and is a Fellow of the Institute of Directors. He joined TauRx in 2020 and oversees all company operational and business functions.
Dr Deborah A. O’Neil OBE FRSE
Founder and Chief Executive Officer, NovaBiotics
Deborah is founder and Chief Executive Officer of Aberdeen-based NovaBiotics, a multi-award-winning biotechnology business with a portfolio of first-in-class solutions for unmet health and personal care needs.
Professor Dame Anna Dominiczak
Chief Scientist (Health), Scottish Government and Regius Professor of Medicine, University of Glasgow
Professor Dame Anna Dominiczak DBE MD FRCP FAHA FMedSci FRSE is Chief Scientist (Health) for the Scottish Government and Regius Professor of Medicine at the University of Glasgow. She is internationally recognised for her leadership in cardiovascular medicine, precision medicine, and health innovation.